Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Heteroresistance to carbapenems in Acinetobacter baumannii.
Pournaras S, Ikonomidis A, Markogiannakis A, Maniatis AN, Tsakris A. Pournaras S, et al. J Antimicrob Chemother. 2005 Jun;55(6):1055-6. doi: 10.1093/jac/dki115. Epub 2005 Apr 11. J Antimicrob Chemother. 2005. PMID: 15824088 No abstract available.
Carriage of OXA-58 but not of OXA-51 beta-lactamase gene correlates with carbapenem resistance in Acinetobacter baumannii.
Tsakris A, Ikonomidis A, Pournaras S, Spanakis N, Markogiannakis A. Tsakris A, et al. J Antimicrob Chemother. 2006 Nov;58(5):1097-9. doi: 10.1093/jac/dkl365. Epub 2006 Sep 22. J Antimicrob Chemother. 2006. PMID: 16997843 No abstract available.
Low genetic diversity of the intrinsic OXA-51-like class D carbapenemases among Acinetobacter baumannii clinical isolates in Greece.
Ikonomidis A, Pournaras S, Markogiannakis A, Maniatis AN, Manolis EN, Tsakris A. Ikonomidis A, et al. Epidemiol Infect. 2007 Jul;135(5):877-81. doi: 10.1017/S0950268806007527. Epub 2006 Nov 17. Epidemiol Infect. 2007. PMID: 17109774 Free PMC article.
This sequence was also the most widespread among A. baumannii isolates in Athens, while less frequent were blaOXA-69 and blaOXA-65 alleles. These findings highlight the high prevalence of a specific blaOXA-51-like allele in Greece, possibly indicating that our A
This sequence was also the most widespread among A. baumannii isolates in Athens, while less frequent were blaOXA-69 and blaOXA-65 al …
Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit.
Pournaras S, Markogiannakis A, Ikonomidis A, Kondyli L, Bethimouti K, Maniatis AN, Legakis NJ, Tsakris A. Pournaras S, et al. J Antimicrob Chemother. 2006 Mar;57(3):557-61. doi: 10.1093/jac/dkl004. Epub 2006 Jan 23. J Antimicrob Chemother. 2006. PMID: 16431857
METHODS: Imipenem-resistant A. baumannii clinical and environmental isolates were collected in the ICU of the Red Cross General Hospital, Athens, Greece between March and October 2002. ...RESULTS: During the study period, 15 clinical and two environmental imipenem-resistan …
METHODS: Imipenem-resistant A. baumannii clinical and environmental isolates were collected in the ICU of the Red Cross General Hospi …
Emergence of resistance to third-generation cephalosporins amongst Salmonella typhimurium isolates in Greece: report of the first three cases.
Tzouvelekis LS, Gazouli M, Markogiannakis A, Paraskaki E, Legakis NJ, Tzelepi E. Tzouvelekis LS, et al. J Antimicrob Chemother. 1998 Aug;42(2):273-5. doi: 10.1093/jac/42.2.273. J Antimicrob Chemother. 1998. PMID: 9738854 No abstract available.
Cross-transmission of multidrug-resistant Acinetobacter baumannii clonal strains causing episodes of sepsis in a trauma intensive care unit.
Markogiannakis A, Fildisis G, Tsiplakou S, Ikonomidis A, Koutsoukou A, Pournaras S, Manolis EN, Baltopoulos G, Tsakris A. Markogiannakis A, et al. Infect Control Hosp Epidemiol. 2008 May;29(5):410-7. doi: 10.1086/533545. Infect Control Hosp Epidemiol. 2008. PMID: 18419362
SETTING: A 7-bed trauma intensive care unit (ICU) in an orthopedic hospital in Greece. DESIGN: During a 14-week period (from January 10 to April 16, 2006), clinical specimens, along with samples taken on a weekly basis from the ICU environment and from the ha …
SETTING: A 7-bed trauma intensive care unit (ICU) in an orthopedic hospital in Greece. DESIGN: During a 14-week period (from J …
Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems.
Pournaras S, Ikonomidis A, Markogiannakis A, Spanakis N, Maniatis AN, Tsakris A. Pournaras S, et al. J Med Microbiol. 2007 Jan;56(Pt 1):66-70. doi: 10.1099/jmm.0.46816-0. J Med Microbiol. 2007. PMID: 17172519
Growth curves revealed a prolonged lag phase and a short exponential phase for the heterogeneous subpopulations compared with their respective native subpopulations. ...
Growth curves revealed a prolonged lag phase and a short exponential phase for the heterogeneous subpopulations compared with …
The influence of local instillation of fusidic acid on the development of microbial complications after lung resection.
Baltayiannis N, Markogiannakis A, Sfyridis P, Manolis EN, Anagnostopoulos D, Bolanos N, Hatzimichalis A, Tsakris A. Baltayiannis N, et al. J Chemother. 2006 Jun;18(3):285-92. doi: 10.1179/joc.2006.18.3.285. J Chemother. 2006. PMID: 17129839
The 290 patients of the first period who underwent 298 thoracotomies received a chemoprophylactic regimen of intravenous cefuroxime while the 202 patients of the second period who underwent 206 thoracotomies were additionally treated with fusidic acid, irrigated with local …
The 290 patients of the first period who underwent 298 thoracotomies received a chemoprophylactic regimen of intravenous cefuroxime w …
Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?
Daikos GL, Markogiannakis A. Daikos GL, et al. Clin Microbiol Infect. 2011 Aug;17(8):1135-41. doi: 10.1111/j.1469-0691.2011.03553.x. Epub 2011 Jun 2. Clin Microbiol Infect. 2011. PMID: 21635663 Review.
Although CPKP isolates are often highly resistant to carbapenems, a proportion of these have relatively low MICs for carbapenems, raising the question of whether this class of agents has any therapeutic potential against CPKP infections. ...The results of human pharmacokin …
Although CPKP isolates are often highly resistant to carbapenems, a proportion of these have relatively low MICs for carbapenems, rai …
Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital.
Petrikkos G, Markogiannakis A, Papaparaskevas J, Daikos GL, Stefanakos G, Zissis NP, Avlamis A. Petrikkos G, et al. Int J Antimicrob Agents. 2007 Jan;29(1):34-8. doi: 10.1016/j.ijantimicag.2006.08.042. Int J Antimicrob Agents. 2007. PMID: 17189092
Data regarding CEP and TZP consumption and resistance were collected on a bimonthly basis during an open-label 2-year (1 year observational and 1 year interventional) study. ...A significant decrease in resistance to third-generation cephalosporins among K. pneumoni …
Data regarding CEP and TZP consumption and resistance were collected on a bimonthly basis during an open-label 2-year (1 year observa …
36 results
Jump to page
Feedback